Position in BNTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$35,120,045
+$306,729 QoQ
Shares Held
377,432
-3.6% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. BNTX ranks #14 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in BNTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,120,045 | 377,432 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $34,813,316 | 391,689 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $42,486,140 | 446,283 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $37,719,780 | 382,476 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $36,792,410 | 345,566 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $26,388,093 | 289,788 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $34,697,772 | 304,500 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $35,363,883 | 297,751 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $28,170,518 | 350,554 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $45,891,422 | 497,468 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $56,659,464 | 536,853 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $59,369,043 | 546,475 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $63,275,146 | 586,261 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $77,215,707 | 619,858 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $91,422,685 | 608,592 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $87,445,263 | 648,319 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $96,992,529 | 650,520 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $88,639,348 | 519,696 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $160,334,325 | 621,933 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $74,714,631 | 273,690 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $90,473,263 | 404,115 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $46,539,614 | 426,226 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $10,344,397 | 126,894 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $34,590,698 | 499,649 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $35,043,503 | 525,075 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,565,996 | 26,815 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||